{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:52:48Z","timestamp":1772837568714,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05154-w","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T10:31:01Z","timestamp":1742207461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liver metastasis from a chromophobe renal cell carcinoma 18\u00a0years after initial diagnosis: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Alexandra","family":"\u00d6kr\u00f6si","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Ponhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Turba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melitta","family":"Kitzw\u00f6gerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6037-7534","authenticated-orcid":false,"given":"Gertraud","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"issue":"1","key":"5154_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"5154_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103287","volume-title":"Comprehensive review of chromophobe renal cell carcinoma","author":"R Garje","year":"2021","unstructured":"Garje R, Elhag D, Yasin HA, Acharya L, Vaena D, Dahmoush L. Comprehensive review of chromophobe renal cell carcinoma. Amsterdam: Elsevier Ireland Ltd; 2021."},{"issue":"5","key":"5154_CR3","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1148\/rg.2021200206","volume":"41","author":"J Marko","year":"2021","unstructured":"Marko J, Craig R, Nguyen A, Udager AM, Wolfman DJ. Chromophobe renal cell carcinoma with radiologic-pathologic correlation. Radiographics. 2021;41(5):1408\u201319.","journal-title":"Radiographics"},{"key":"5154_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pathol.2020.09.015","author":"H Moch","year":"2021","unstructured":"Moch H, Ohashi R. Chromophobe renal cell carcinoma: current and controversial issues. Pathology. 2021. https:\/\/doi.org\/10.1016\/j.pathol.2020.09.015.","journal-title":"Pathology"},{"key":"5154_CR5","unstructured":"Bahadoram S, Davoodi M, Hassanzadeh S, Bahadoram M, Barahman M, Mafakher L. Giornale. Italiano di Nefrologia In Depth Review. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment. 2022"},{"key":"5154_CR6","unstructured":"Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, et\u00a0al. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt\u2013Hogg\u2013Dub\u00e9 syndrome."},{"issue":"6","key":"5154_CR7","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.juro.2013.06.012","volume":"190","author":"B Shuch","year":"2013","unstructured":"Shuch B, Ricketts CJ, Vocke CD, Komiya T, Middelton LA, Kauffman EC, et\u00a0al. Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer. J Urol. 2013;190(6):1990\u20138.","journal-title":"J Urol"},{"key":"5154_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-018-2288-5","author":"ER Maher","year":"2018","unstructured":"Maher ER. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management. World J Urol. 2018. https:\/\/doi.org\/10.1007\/s00345-018-2288-5.","journal-title":"World J Urol"},{"key":"5154_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101492","author":"R Ohashi","year":"2019","unstructured":"Ohashi R, Schraml P, Angori S, Batavia AA, Rupp NJ, Ohe C, et\u00a0al. Classic chromophobe renal cell carcinoma incur a larger number of chromosomal losses than seen in the eosinophilic subtype. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11101492.","journal-title":"Cancers (Basel)"},{"key":"5154_CR10","first-page":"10","volume":"12","author":"MH Tan","year":"2010","unstructured":"Tan MH, Wong CF, Tan HL, Yang XJ, Ditlev J, Matsuda D, et\u00a0al. Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer. 2010;12:10.","journal-title":"BMC Cancer"},{"issue":"1","key":"5154_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng.3146","volume":"47","author":"S Durinck","year":"2015","unstructured":"Durinck S, Stawiski EW, Pav\u00eda-Jim\u00e9nez A, Modrusan Z, Kapur P, Jaiswal BS, et\u00a0al. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet. 2015;47(1):13\u201321.","journal-title":"Nat Genet"},{"issue":"5","key":"5154_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.clgc.2019.06.011","volume":"17","author":"J Casuscelli","year":"2019","unstructured":"Casuscelli J, Becerra MF, Seier K, Manley BJ. Chromophobe renal cell carcinoma: results from a large single-institution series. Clin Genitourin Cancer. 2019;17(5):373\u20139.","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"5154_CR13","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/annonc\/mdz056","volume":"30","author":"B Escudier","year":"2019","unstructured":"Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, et\u00a0al. Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(5):706\u201320.","journal-title":"Ann Oncol"},{"issue":"14","key":"5154_CR14","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1056\/NEJMoa2035716","volume":"384","author":"R Motzer","year":"2021","unstructured":"Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, et\u00a0al. Lenvatinib plus pembrolizumab or everolimus for advanced renal cell carcinoma. N Engl J Med. 2021;384(14):1289\u2013300.","journal-title":"N Engl J Med"},{"key":"5154_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/10781552231178461","author":"C Eisinger","year":"2023","unstructured":"Eisinger C, Muluneh B. Combined use of pembrolizumab and lenvatinib: a review. J Oncol Pharmacy Pract. 2023. https:\/\/doi.org\/10.1177\/10781552231178461.","journal-title":"J Oncol Pharmacy Pract"},{"key":"5154_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajur.2021.11.010","author":"R Alaghehbandan","year":"2022","unstructured":"Alaghehbandan R, Przybycin CG, Verkarre V, Mehra R. Chromophobe renal cell carcinoma: novel molecular insights and clinicopathologic updates. Asian J Urol. 2022. https:\/\/doi.org\/10.1016\/j.ajur.2021.11.010.","journal-title":"Asian J Urol"},{"key":"5154_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00428-019-02710-w","volume":"476","author":"R Ohashi","year":"2020","unstructured":"Ohashi R, Martignoni G, Hartmann A, Calio A, Segala D, St\u00f6hr C. Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme. Virchows Arch. 2020;476:409\u201318.","journal-title":"Virchows Arch"},{"issue":"7","key":"5154_CR18","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/cncr.20128","volume":"100","author":"M Peyromaure","year":"2004","unstructured":"Peyromaure M, Misrai V, Thiounn N, Vieillefond A, Zerbib M, Flam TA, et\u00a0al. Chromophobe renal cell carcinoma: analysis of 61 cases. Cancer. 2004;100(7):1406\u201310.","journal-title":"Cancer"},{"issue":"5","key":"5154_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.euf.2018.02.010","volume":"5","author":"S Dabestani","year":"2019","unstructured":"Dabestani S, Beisland C, Stewart GD, Bensalah K, Gudmundsson E, Lam TB, et\u00a0al. Long-term outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR database analysis. Eur Urol Focus. 2019;5(5):857\u201366.","journal-title":"Eur Urol Focus"},{"issue":"3","key":"5154_CR20","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S1470-2045(15)00515-X","volume":"17","author":"AJ Armstrong","year":"2016","unstructured":"Armstrong AJ, Halabi S, Eisen T, Broderick S, Stadler WM, Jones RJ. Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial. Lancet Oncol. 2016;17(3):378\u201388.","journal-title":"Lancet Oncol"},{"issue":"3","key":"5154_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","volume":"26","author":"CF Davis","year":"2014","unstructured":"Davis CF, Ricketts CJ, Wang M, Yang L, Cherniack AD, Shen H. The somatic genomic landscape of chromophobe renal cell carcinoma. Cancer Cell. 2014;26(3):319\u201330.","journal-title":"Cancer Cell"},{"issue":"2","key":"5154_CR22","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4143\/crt.2016.584","volume":"50","author":"KS Jung","year":"2018","unstructured":"Jung KS, Lee SJ, Park SH, Lee JL. Pazopanib for the treatment of non-clear cell renal cell carcinoma: a single-arm, open-label, multicenter, phase II study. Cancer Reas Treat. 2018;50(2):488\u201394.","journal-title":"Cancer Reas Treat"},{"issue":"4","key":"5154_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.clgc.2016.12.024","volume":"15","author":"S Buti","year":"2017","unstructured":"Buti S, Bersanelli M, Maines F, Facchini G, Gelsomino F. First-line PAzopanib in NOn-clear-cell Renal cArcinoMA: the Italian retrospective Multicenter PANORAMA Study. Clin Genitourin Cancer. 2017;15(4):609\u201314.","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"5154_CR24","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3390\/cancers15092500","volume":"15","author":"DD Shapiro","year":"2023","unstructured":"Shapiro DD, Dolan B, Laklouk IA, Rassi S, Lozar T, Emamekhoo H, et\u00a0al. Understanding the tumor immune microenvironment in renal cell carcinoma. Cancers (Basel). 2023;15(9):2500.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5154_CR25","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, et\u00a0al. The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep. 2018;23(1):313-326.e5.","journal-title":"Cell Rep"},{"issue":"4","key":"5154_CR26","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41591-022-01694-6","volume":"28","author":"N Dizman","year":"2022","unstructured":"Dizman N, Meza L, Bergerot P, Alcantara M, Dorff T, Lyou Y, et\u00a0al. Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial. Nat Med. 2022;28(4):704\u201312.","journal-title":"Nat Med"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05154-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05154-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05154-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T10:31:05Z","timestamp":1742207465000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05154-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5154"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05154-w","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors certify that this case report was performed in accordance with ethical standards as laid down in the Declaration of Helsinki and its later amendments, or comparable ethical standards for research involving human participants and\/or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"A written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}